| Literature DB >> 32317438 |
Govindarajan Ramadoss1, Dayakar Yadalla2.
Abstract
Purpose: To perform an analysis of ophthalmic literature published by the Indian journal of ophthalmology (IJO) between 2005 and 2017 using scientometric techniques.Entities:
Keywords: IJO; Indian Journal of Ophthalmology; Indian Ophthalmic Research; ophthalmology; scientometric
Mesh:
Year: 2020 PMID: 32317438 PMCID: PMC7350431 DOI: 10.4103/ijo.IJO_1213_19
Source DB: PubMed Journal: Indian J Ophthalmol ISSN: 0301-4738 Impact factor: 1.848
Published literature in IJO during the period 2005-2017
| Year | No. of literature (C) | Percentage (C/N) | Growth rate |
|---|---|---|---|
| 2005 | 74 | 2.8% | |
| 2006 | 92 | 3.5% | 24.3% |
| 2007 | 164 | 6.2% | 78.3% |
| 2008 | 152 | 5.8% | -7.3% |
| 2009 | 132 | 5.0% | -13.2% |
| 2010 | 165 | 6.3% | 25.0% |
| 2011 | 192 | 7.3% | 16.4% |
| 2012 | 160 | 6.1% | -16.7% |
| 2013 | 257 | 9.8% | 60.6% |
| 2014 | 334 | 12.7% | 30.0% |
| 2015 | 290 | 11.0% | -13.2% |
| 2016 | 266 | 10.1% | -8.3% |
| 2017 | 355 | 13.5% | 33.5% |
| Total | 2,633 (N) | 100% |
Figure 1Time trends in the number of articles published in the IJO from 2005 to 2017
Subspecialty wise distribution of articles over the study period
| Subject | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cataract and IOL | 6 (8.1%) | 10 (10.9%) | 19 (11.6%) | 11 (7.2%) | 18 (13.6%) | 24 (14.5%) | 16 (8.3%) | 17 (10.6%) | 24 (9.3%) | 43 (12.9%) | 24 (8.3%) | 21 (7.9%) | 60 (16.9%) | 293 (11.1%) |
| Community ophthalmology | 1 (1.4%) | 1 (1.1%) | 0 (0%) | 1 (0.7%) | 2 (1.5%) | 5 (3%) | 2 (1%) | 9 (5.6%) | 4 (1.6%) | 6 (1.8%) | 5 (1.7%) | 9 (3.4%) | 5 (1.4%) | 50 (1.9%) |
| Cornea | 11 (14.9%) | 14 (15.2%) | 34 (20.7%) | 22 (14.5%) | 12 (9.1%) | 19 (11.5%) | 27 (14.1%) | 19 (11.9%) | 39 (15.2%) | 29 (8.7%) | 13 (4.5%) | 21 (7.9%) | 53 (14.9%) | 313 (11.9%) |
| General Ophthalmology | 0 (0%) | 0 (0%) | 1 (0.6%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 5 (1.4%) | 6 (0.2%) |
| Glaucoma | 6 (8.1%) | 6 (6.5%) | 3 (1.8%) | 6 (3.9%) | 11 (8.3%) | 10 (6.1%) | 39 (20.3%) | 5 (3.1%) | 16 (6.2%) | 31 (9.3%) | 21 (7.2%) | 23 (8.6%) | 18 (5.1%) | 195 (7.4%) |
| Miscellaneous | 9 (12.2%) | 10 (10.9%) | 14 (8.5%) | 19 (12.5%) | 18 (13.6%) | 17 (10.3%) | 13 (6.8%) | 50 (31.3%) | 39 (15.2%) | 73 (21.9%) | 87 (30%) | 62 (23.3%) | 34 (9.6%) | 445 (16.9%) |
| Neurophthalmology | 3 (4.1%) | 5 (5.4%) | 6 (3.7%) | 6 (3.9%) | 9 (6.8%) | 6 (3.6%) | 13 (6.8%) | 5 (3.1%) | 12 (4.7%) | 29 (8.7%) | 7 (2.4%) | 11 (4.1%) | 19 (5.4%) | 131 (5%) |
| Oncology | 0 (0%) | 1 (1.1%) | 2 (1.2%) | 0 (0%) | 0 (0%) | 1 (0.6%) | 0 (0%) | 1 (0.6%) | 2 (0.8%) | 9 (2.7%) | 27 (9.3%) | 12 (4.5%) | 13 (3.7%) | 68 (2.6%) |
| Optics and Refraction | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 2 (1%) | 2 (1.3%) | 3 (1.2%) | 4 (1.2%) | 1 (0.3%) | 0 (0%) | 0 (0%) | 12 (0.5%) |
| Orbit and Oculoplasty | 11 (14.9%) | 11 (12%) | 14 (8.5%) | 28 (18.4%) | 17 (12.9%) | 10 (6.1%) | 18 (9.4%) | 9 (5.6%) | 19 (7.4%) | 29 (8.7%) | 24 (8.3%) | 32 (12%) | 18 (5.1%) | 240 (9.1%) |
| Pediatric ophthalmology | 1 (1.4%) | 6 (6.5%) | 4 (2.4%) | 3 (2%) | 6 (4.5%) | 5 (3%) | 5 (2.6%) | 4 (2.5%) | 2 (0.8%) | 4 (1.2%) | 2 (0.7%) | 2 (0.8%) | 18 (5.1%) | 62 (2.4%) |
| Refractive Surgery | 0 (0%) | 0 (0%) | 1 (0.6%) | 0 (0%) | 0 (0%) | 1 (0.6%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 1 (0.3%) | 0 (0%) | 0 (0%) | 3 (0.1%) |
| Retina | 23 (31.1%) | 21 (22.8%) | 50 (30.5%) | 33 (21.7%) | 25 (18.9%) | 43 (26.1%) | 52 (27.1%) | 33 (20.6%) | 69 (26.8%) | 61 (18.3%) | 56 (19.3%) | 51 (19.2%) | 81 (22.8%) | 598 (22.7%) |
| Squint | 0 (0%) | 1 (1.1%) | 6 (3.7%) | 12 (7.9%) | 8 (6.1%) | 9 (5.5%) | 4 (2.1%) | 3 (1.9%) | 7 (2.7%) | 11 (3.3%) | 12 (4.1%) | 5 (1.9%) | 11 (3.1%) | 89 (3.4%) |
| Trauma | 0 (0%) | 1 (1.1%) | 2 (1.2%) | 2 (1.3%) | 0 (0%) | 2 (1.2%) | 0 (0%) | 0 (0%) | 6 (2.3%) | 3 (0.9%) | 2 (0.7%) | 5 (1.9%) | 4 (1.1%) | 27 (1%) |
| Uvea | 3 (4.1%) | 5 (5.4%) | 8 (4.9%) | 9 (5.9%) | 6 (4.5%) | 13 (7.9%) | 1 (0.5%) | 3 (1.9%) | 15 (5.8%) | 2 (0.6%) | 8 (2.8%) | 12 (4.5%) | 16 (4.5%) | 101 (3.8%) |
| Total | 74 (100%) | 92 (100%) | 164 (100%) | 152 (100%) | 132 (100%) | 165 (100%) | 192 (100%) | 160 (100%) | 257 (100%) | 334 (100%) | 290 (100%) | 266 (100%) | 355 (100%) | 2633 (100%) |
Type of article and distribution over the study period
| Publication type | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Case report | 28 (37.8%) | 38 (41.3%) | 78 (47.6%) | 65 (42.8%) | 51 (38.6%) | 61 (37%) | 61 (31.8%) | 52 (32.5%) | 77 (30%) | 92 (27.5%) | 82 (28.3%) | 98 (36.8%) | 28 (37.8%) | 894 (34%) |
| Editorial | 4 (5.4%) | 4 (4.3%) | 8 (4.9%) | 7 (4.6%) | 6 (4.5%) | 5 (3%) | 8 (4.2%) | 7 (4.4%) | 16 (6.2%) | 12 (3.6%) | 16 (5.5%) | 14 (5.3%) | 4 (5.4%) | 138 (5.2%) |
| Letter to editor | 10 (13.5%) | 13 (14.1%) | 22 (13.4%) | 20 (13.2%) | 18 (13.6%) | 42 (25.5%) | 40 (20.8%) | 25 (15.6%) | 55 (21.4%) | 55 (16.5%) | 75 (25.9%) | 41 (15.4%) | 10 (13.5%) | 437 (16.6%) |
| Original article | 28 (37.8%) | 25 (27.2%) | 36 (22%) | 46 (30.3%) | 46 (34.8%) | 48 (29.1%) | 68 (35.4%) | 48 (30%) | 74 (28.8%) | 144 (43.1%) | 77 (26.6%) | 92 (34.6%) | 28 (37.8%) | 862 (32.7%) |
| Others | 3 (4.1%) | 6 (6.5%) | 10 (6.1%) | 5 (3.3%) | 6 (4.5%) | 4 (2.4%) | 7 (3.6%) | 3 (1.9%) | 8 (3.1%) | 11 (3.3%) | 12 (4.1%) | 6 (2.3%) | 3 (4.1%) | 100 (3.8%) |
| Review article | 1 (1.4%) | 6 (6.5%) | 10 (6.1%) | 9 (5.9%) | 5 (3.8%) | 5 (3%) | 8 (4.2%) | 25 (15.6%) | 27 (10.5%) | 20 (6%) | 28 (9.7%) | 15 (5.6%) | 1 (1.4%) | 202 (7.7%) |
| Total | 74 (100%) | 92 (100%) | 164 (100%) | 152 (100%) | 132 (100%) | 165 (100%) | 192 (100%) | 160 (100%) | 257 (100%) | 334 (100%) | 290 (100%) | 266 (100%) | 74 (100%) | 2633 (100%) |
Subject-wise distribution of article type over the study period
| Subject | Review Article | Original Article | Editorial | Letter to Editor | Case Report | Others | Total |
|---|---|---|---|---|---|---|---|
| Cataract & IOL | 20 (9.9%) | 111 (12.9%) | 4 (2.9%) | 65 (14.9%) | 75 (8.4%) | 18 (18%) | 293 (11.1%) |
| Community ophthalmology | 6 (3%) | 32 (3.7%) | 3 (2.2%) | 5 (1.1%) | 2 (0.2%) | 2 (2%) | 501 (1.9%) |
| Cornea | 33 (16.3%) | 117 (13.6%) | 8 (5.8%) | 26 (5.9%) | 117 (13.1%) | 12 (12%) | 313 (11.9%) |
| General Ophthalmology | 0 (0%) | 2 (0.2%) | 2 (1.4%) | 1 (0.2%) | 1 (0.1%) | 0 (0%) | 6 (0.2%) |
| Glaucoma | 12 (5.9%) | 112 (13%) | 6 (4.3%) | 18 (4.1%) | 33 (3.7%) | 14 (14%) | 195 (7.4%) |
| Miscellaneous | 40 (19.8%) | 116 (13.5%) | 86 (62.3%) | 111 (25.4%) | 69 (7.7%) | 23 (23%) | 445 (16.9%) |
| Neurophthalmology | 9 (4.5%) | 37 (4.3%) | 0 (0%) | 22 (5%) | 63 (7%) | 0 (0%) | 131 (5%) |
| Oncology | 16 (7.9%) | 13 (1.5%) | 3 (2.2%) | 5 (1.1%) | 30 (3.4%) | 1 (1%) | 68 (2.6%) |
| Optics and Refraction | 1 (0.5%) | 7 (0.8%) | 0 (0%) | 3 (0.7%) | 1 (0.1%) | 0 (0%) | 12 (0.5%) |
| Orbit and Oculoplasty | 14 (6.9%) | 47 (5.5%) | 1 (0.7%) | 30 (6.9%) | 142 (15.9%) | 6 (6%) | 240 (9.1%) |
| Pediatric ophthalmology | 2 (1%) | 30 (3.5%) | 4 (2.9%) | 17 (3.9%) | 8 (0.9%) | 1 (1%) | 62 (2.4%) |
| Refractive Surgery | 0 (0%) | 2 (0.2%) | 0 (0%) | 0 (0%) | 0 (0%) | 1 (1%) | 3 (0.1%) |
| Retina | 28 (13.9%) | 182 (21.1%) | 16 (11.6%) | 97 (22.2%) | 262 (29.3%) | 13 (13%) | 598 (22.7%) |
| Squint | 2 (1%) | 31 (3.6%) | 1 (0.7%) | 25 (5.7%) | 25 (2.8%) | 5 (5%) | 89 (3.4%) |
| Trauma | 0 (0%) | 8 (0.9%) | 1 (0.7%) | 2 (0.5%) | 15 (1.7%) | 1 (1%) | 27 (1%) |
| Uvea | 19 (9.4%) | 15 (1.7%) | 3 (2.2%) | 10 (2.3%) | 51 (5.7%) | 3 (3%) | 101 (3.8%) |
| Total | 202 (100%) | 862 (100%) | 138 (100%) | 437 (100%) | 894 (100%) | 100 (100%) | 2633 (100%) |
Subject-wise reference count distribution over years
| Subject | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cataract and IOL | 1 (0.2%) | 3 (10.3%) | 47 (6.8%) | 137 (6.8%) | 338 (19.5%) | 269 (14.2%) | 214 (7.2%) | 212 (10.2%) | 265 (8.2%) | 630 (12.1%) | 242 (5.6%) | 292 (7.7%) | 1328 (20.4%) | 3978 (11.4%) |
| Community ophthalmology | 1 (0.2%) | 0 (0%) | 0 (0%) | 20 (1%) | 8 (0.5%) | 86 (4.5%) | 21 (0.7%) | 150 (7.2%) | 33 (1%) | 114 (2.2%) | 94 (2.2%) | 194 (5.1%) | 99 (1.5%) | 820 (2.3%) |
| Cornea | 130 (30.2%) | 2 (6.9%) | 67 (9.6%) | 330 (16.3%) | 278 (16%) | 151 (8%) | 267 (9%) | 334 (16%) | 660 (20.5%) | 480 (9.2%) | 255 (5.9%) | 334 (8.8%) | 1190 (18.3%) | 4478 (12.8%) |
| General Ophthalmology | 0 (0%) | 0 (0%) | 1 (0.1%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 35 (0.5%) | 36 (0.1%) |
| Glaucoma | 24 (5.6%) | 6 (20.7%) | 0 (0%) | 108 (5.3%) | 262 (15.1%) | 143 (7.6%) | 1288 (43.2%) | 134 (6.4%) | 243 (7.5%) | 746 (14.3%) | 517 (11.9%) | 442 (11.7%) | 393 (6%) | 4306 (12.3%) |
| Miscellaneous | 49 (11.4%) | 2 (6.9%) | 50 (7.2%) | 303 (15%) | 153 (8.8%) | 154 (8.1%) | 147 (4.9%) | 581 (27.9%) | 408 (12.7%) | 1061 (20.3%) | 1065 (24.5%) | 741 (19.6%) | 492 (7.6%) | 5206 (14.9%) |
| Neurophthalmology | 12 (2.8%) | 2 (6.9%) | 24 (3.5%) | 78 (3.9%) | 88 (5.1%) | 47 (2.5%) | 294 (9.9%) | 33 (1.6%) | 118 (3.7%) | 519 (9.9%) | 42 (1%) | 111 (2.9%) | 290 (4.5%) | 1658 (4.7%) |
| Oncology | 0 (0%) | 0 (0%) | 17 (2.4%) | 0 (0%) | 0 (0%) | 8 (0.4%) | 0 (0%) | 24 (1.2%) | 66 (2%) | 101 (1.9%) | 786 (18%) | 218 (5.8%) | 204 (3.1%) | 1424 (4.1%) |
| Optics and Refraction | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 7 (0.2%) | 29 (1.4%) | 22 (0.7%) | 78 (1.5%) | 1 (0%) | 0 (0%) | 0 (0%) | 137 (0.4%) |
| Orbit and Oculoplasty | 24 (5.6%) | 2 (6.9%) | 33 (4.7%) | 210 (10.4%) | 177 (10.2%) | 69 (3.6%) | 154 (5.2%) | 123 (5.9%) | 136 (4.2%) | 314 (6%) | 267 (6.1%) | 493 (13%) | 225 (3.5%) | 2227 (6.4%) |
| Pediatric ophthalmology | 1 (0.2%) | 6 (20.7%) | 1 (0.1%) | 60 (3%) | 53 (3.1%) | 30 (1.6%) | 46 (1.5%) | 54 (2.6%) | 10 (0.3%) | 86 (1.6%) | 9 (0.2%) | 56 (1.5%) | 343 (5.3%) | 755 (2.2%) |
| Refractive Surgery | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 28 (1.5%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 1 (0%) | 0 (0%) | 0 (0%) | 29 (0.1%) |
| Retina | 180 (41.9%) | 5 (17.2%) | 412 (59.3%) | 424 (21%) | 209 (12%) | 425 (22.5%) | 511 (17.2%) | 388 (18.6%) | 810 (25.1%) | 845 (16.2%) | 799 (18.3%) | 661 (17.5%) | 1418 (21.8%) | 7087 (20.3%) |
| Squint | 0 (0%) | 0 (0%) | 15 (2.2%) | 110 (5.4%) | 123 (7.1%) | 71 (3.8%) | 20 (0.7%) | 11 (0.5%) | 63 (2%) | 184 (3.5%) | 112 (2.6%) | 36 (1%) | 175 (2.7%) | 920 (2.6%) |
| Trauma | 0 (0%) | 0 (0%) | 6 (0.9%) | 22 (1.1%) | 0 (0%) | 16 (0.8%) | 0 (0%) | 0 (0%) | 71 (2.2%) | 24 (0.5%) | 13 (0.3%) | 24 (0.6%) | 52 (0.8%) | 228 (0.7%) |
| Uvea | 8 (1.9%) | 1 (3.4%) | 22 (3.2%) | 217 (10.7%) | 46 (2.7%) | 394 (20.8%) | 10 (0.3%) | 8 (0.4%) | 318 (9.9%) | 45 (0.9%) | 152 (3.5%) | 183 (4.8%) | 263 (4%) | 1667 (4.8%) |
| Total | 430 | 29 | 695 | 2019 | 1735 | 1891 | 2979 | 2081 | 3223 | 5227 | 4355 | 3785 | 6507 | 34956 |
Figure 2Distribution of unique authors per year and cumulative authors over the study period
Figure 3Citation patterns over time
Subject-wise citation count distribution over years
| Subject | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cataract and IOL | 174 (10.2%) | 90 (6.4%) | 155 (5.1%) | 131 (4.6%) | 471 (17.4%) | 253 (10.7%) | 159 (6.1%) | 144 (7%) | 198 (10.4%) | 269 (12.7%) | 60 (5.1%) | 68 (10.6%) | 58 (14.9%) | 2230 (8.9%) |
| Community ophthalmology | 4 (0.2%) | 26 (1.9%) | 0 (0%) | 114 (4%) | 20 (0.7%) | 128 (5.4%) | 19 (0.7%) | 329 (16%) | 44 (2.3%) | 65 (3.1%) | 30 (2.5%) | 79 (12.3%) | 12 (3.1%) | 870 (3.5%) |
| Cornea | 492 (28.8%) | 305 (21.8%) | 826 (27.1%) | 376 (13.2%) | 593 (21.9%) | 216 (9.2%) | 324 (12.5%) | 216 (10%) | 661 (34.6%) | 175 (8.3%) | 79 (6.7%) | 61 (9.5%) | 68 (17.4%) | 4392 (17.6%) |
| General ophthalmology | 0 (0%) | 0 (0%) | 1 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 3 (0.8%) | 4 (0%) |
| Glaucoma | 276 (16.2%) | 132 (9.4%) | 100 (3.3%) | 135 (4.8%) | 360 (13.3%) | 163 (6.9%) | 870 (33.6%) | 89 (4.3%) | 112 (5.9%) | 210 (9.9%) | 85 (7.2%) | 50 (7.8%) | 14 (3.6%) | 2596 (10.4%) |
| Miscellaneous | 140 (8.2%) | 77 (5.5%) | 171 (5.6%) | 773 (27.2%) | 267 (9.8%) | 318 (13.5%) | 126 (4.9%) | 586 (28%) | 91 (4.8%) | 380 (18%) | 234 (19.8%) | 105 (16.4%) | 49 (12.6%) | 3317 (13.3%) |
| Neuro-Ophthalmology | 39 (2.3%) | 77 (5.5%) | 116 (3.8%) | 64 (2.3%) | 100 (3.7%) | 82 (3.5%) | 322 (12.4%) | 103 (5%) | 91 (4.8%) | 207 (9.8%) | 21 (1.8%) | 16 (2.5%) | 10 (2.6%) | 1248 (5%) |
| Oncology | 0 (0%) | 9 (0.6%) | 47 (1.5%) | 0 (0%) | 0 (0%) | 3 (0.1%) | 0 (0%) | 2 (0.1%) | 36 (1.9%) | 43 (2%) | 233 (19.7%) | 35 (5.5%) | 23 (5.9%) | 431 (1.7%) |
| Optics and Refraction | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 14 (0.5%) | 76 (3.7%) | 14 (0.7%) | 40 (1.9%) | 0 (0%) | 0 (0%) | 0 (0%) | 144 (0.6%) |
| Orbit and Oculoplasty | 121 (7.1%) | 184 (13.1%) | 182 (6%) | 321 (11.3%) | 231 (8.5%) | 91 (3.9%) | 170 (6.6%) | 116 (5.6%) | 76 (4%) | 105 (5%) | 73 (6.2%) | 66 (10.3%) | 15 (3.8%) | 1751 (7%) |
| Pediatric ophthalmology | 26 (1.5%) | 69 (4.9%) | 76 (2.5%) | 49 (1.7%) | 89 (3.3%) | 33 (1.4%) | 40 (1.5%) | 27 (1.3%) | 6 (0.3%) | 72 (3.4%) | 1 (0.1%) | 9 (1.4%) | 27 (6.9%) | 524 (2.1%) |
| Refractive Surgery | 0 (0%) | 0 (0%) | 9 (0.3%) | 0 (0%) | 0 (0%) | 22 (0.9%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | 31 (0.1%) |
| Retina | 404 (23.7%) | 356 (25.4%) | 965 (31.7%) | 394 (13.9%) | 355 (13.1%) | 678 (28.7%) | 529 (20.4%) | 331 (16%) | 377 (19.7%) | 452 (21.4%) | 290 (24.5%) | 125 (19.5%) | 80 (20.5%) | 5336 (21.4%) |
| Squint | 0 (0%) | 5 (0.4%) | 71 (2.3%) | 238 (8.4%) | 90 (3.3%) | 39 (1.7%) | 11 (0.4%) | 12 (0.6%) | 24 (1.3%) | 72 (3.4%) | 21 (1.8%) | 1 (0.2%) | 9 (2.3%) | 593 (2.4%) |
| Trauma | 0 (0%) | 0 (0%) | 15 (0.5%) | 86 (3%) | 0 (0%) | 9 (0.4%) | 0 (0%) | 0 (0%) | 72 (3.8%) | 14 (0.7%) | 10 (0.8%) | 2 (0.3%) | 7 (1.8%) | 215 (0.9%) |
| Uvea | 32 (1.9%) | 70 (5%) | 313 (10.3%) | 158 (5.6%) | 135 (5%) | 324 (13.7%) | 7 (0.3%) | 24 (1.2%) | 109 (5.7%) | 12 (0.6%) | 46 (3.9%) | 25 (3.9%) | 15 (3.8%) | 1270 (5.1%) |
| Total | 1708 (100%) | 1400 (100%) | 3047 (100%) | 2839 (100%) | 2711 (100%) | 2359 (100%) | 2591 (100%) | 2055 (100%) | 1911 (100%) | 2116 (100%) | 1183 (100%) | 642 (100%) | 390 (100%) | 24952 (100%) |